期刊文献+

妊娠高血压疾病胎盘组织ACE2和ACE的表达及其临床意义 被引量:8

Expressions of ACE and ACE2 in placenta in patients with pregnancy Induced hypertension and their clinical significance
下载PDF
导出
摘要 目的探讨血管紧张素转换酶2(ACE2)以及血管紧张素转换酶(ACE)在妊娠高血压疾病中的表达及其临床意义。方法用逆转录酶-聚合酶链反应(RT-PCR)测定2010年6月—2011年12月入住我院的50例妊娠高血压疾病、30例无妊娠高血压疾病病史的足月妊娠孕妇,手术取材其胎盘组织检测其胎盘组织中ACE2 mRNA和ACE mRNA表达水平。结果妊娠高血压疾病患者胎盘组织的ACE2 mRNA和ACE mRNA表达均较对照组明显升高,差异有显著统计学意义(P<0.01),妊娠高血压疾病患者胎盘组织的ACE2 mRNA和ACE mRNA随病情的加重而升高,重度妊娠高血压疾病患者升高更为显著(P<0.01);轻中度妊娠高血压疾病患者胎盘组织ACE2 mRNA/ACE mRNA比值较正常组升高,而重度患者其比值较正常组降低。结论妊娠高血压疾病患者组织ACE2和ACE基因表达明显增强;轻中度妊娠高血压疾病患者胎盘组织ACE2 mRNA/ACE mRNA比值升高可能是一种代偿机制,导致AngⅡ的降解,促进AngⅠ-7合成,降低血压及改善胎盘功能,而重度妊娠高血压疾病导致代偿功能减退,最终加剧病情恶化。 Objective TO explore the expressions of placenta ACE and ACE2 in patients with pregnancy induced hypertension and their clinical significance. Methods ACE and ACE2 were measured via RT-PCR in 50 women with pregnancy induced hypertension and 30 ones without hypertension admitted to our hospital from June 2010 to December 2011. Results The expressions of ACE2 and ACE mRNA were significantly higher in the patients with pregnancy induced hypertension than in the controls ( P 〈 0. O1 ) , especially in those with severe pregnancy induced hypertension (P 〈 0.01 ). The ACE2/ACE mRNA ratio increased in the patients with mild-middle pregnancy induced hypertension and decreased in those with severe pregnancy induced hypertension, when com- pare with the controls. Conclusion The expressions of ACE2 and ACE were up-regulated in patients with pregnancy induced hy- pertension. The increased ACE2/ACE mRNA ratio in the patients with mild-middle pregnancy induced hypertension may be due to compensation, indicating the promotion of Ang Ⅱ degradation and Ang 1-7 synthesis. The decreased ACE2/ACE mRNA ratio in the patients with severe pregnancy induced hypertension suggested that Ang Ⅱ level accelerated the disease progression.
作者 贾春文 熊勋
出处 《临床军医杂志》 CAS 2015年第1期62-64,共3页 Clinical Journal of Medical Officers
关键词 妊娠高血压疾病 胎盘组织 血管紧张素转换酶2 血管紧张素转换酶 pregnancy induced hypertension placenta angiotensin converting enzyme 2 angiotensin converting enzyme
  • 相关文献

参考文献4

二级参考文献93

  • 1段涛,应豪.妊娠期高血压疾病的早期预防[J].中国实用妇科与产科杂志,2004,20(10):584-586. 被引量:41
  • 2段涛.妊娠期高血压疾病的热点问题讨论[J].现代妇产科进展,2004,13(6):401-405. 被引量:64
  • 3Bataller R, Gabele E, Parsons CJ, Morris T, Yang L, Schoonhoven R, Brenner DA, Rippe RA. Systemic hafusion of angiotensin Ⅱ exacerbates liver fibrosis in bile ductligated rats. Hepatology 2005; 41:1046-1055.
  • 4Blendis L, Wong F. The hyperdynamic circulation in cirrhosis: an overview. Pharmacol Ther 2001; 89:221-231.
  • 5Mezzano SA, Ruiz-Ortega M, Egido J. Angiotensin Ⅱ and renal fibrosis. Hypertension 2001; 38:635-638.
  • 6Yang J, Dai C, Liu Y. Hepatocyte growth factor gene therapy and angiotensin Ⅱ blockade synergistically attenuate renal interstitial fibrosis in mice. J Am Soc Nephrol 2002; 13: 2464-2477.
  • 7Kim S, Iwao H. Molecular and cellular mechanisms of angiotensin If-mediated cardiovascular and renal diseases. Pharmacol Rev 2000; 52:11-34.
  • 8Yu L, Noble NA, Border WA. Therapeutic strategies to halt renal fibrosis. Curr Opin Pharmacol 2002; 2:177-181.
  • 9Burdmann EA, Andoh TF, Nast CC, Evan A, Connors BA, Coffman TM, Lindsley J, Bennett WM. Prevention of experimental cyclosporin-induced interstitial fibrosis by losartan and enalapril. Am J Physiol 1995; 269:F491-F499.
  • 10Kaneto H, Morrissey J, McCracken R, Reyes A, Klahr S. Enalapril reduces collagen type IV synthesis and expansion of the interstitium in the obstructed rat kidney. Kidney Int 1994; 45:1637-1647.

共引文献71

同被引文献96

  • 1张启新.糖尿病健康教育研究进展(综述)[J].继续医学教育,2012,26(3):59-62. 被引量:75
  • 2雷马香,刘筱娴.妊娠高血压疾病危险因素的病例对照研究[J].中国社会医学杂志,2009,26(3):177-179. 被引量:19
  • 3冯启明,李慕军,黄星,李向红,黎燕宁,李敏清,黄志碧.妊娠高血压综合征危险因素的Logistic回归分析[J].广西医科大学学报,2004,21(3):325-327. 被引量:14
  • 4刘云梅,于春梅.妊娠期高血压病的危险因素[J].中国社区医师(医学专业),2007,9(12):3-3. 被引量:18
  • 5Phadungkiatwattana P, Rujiawetpongstom J, Tansathit T, et al. Pregnancy outcomes of Southeast Asian immigrant preg- nant women compared with Thaipregnant women in Rajivithi- Hospital[ J]. Med Assoc Thai,2011,94(2) :147 - 151.
  • 6Szabo G,Rigo J Jr, Nagy B. Physiology and clinical role of the natriuretic peptides [ J ]. Orv Hetil, 2011,152 ( 26 ) : 1025 - 1034.
  • 7Verano-Braga T, Sehwammle V, Sylvester M. Time-resolved quantitative phosphoproteomies: new insights into Angiotensin- (1-7 ) signaling networks in human endothelial cells. J Proteome Res, 2012,11 : 3370-3381.
  • 8Silva DM, Vianna HR, Cortes SF, et al. Evidence for a new angiotensin-(1-7) receptor subtype in the aorta of Sprague-Daw- ley rats. Peptides, 2007,28 : 702-707.
  • 9Sampaio WO, Souza dos Santos RA, Faria-Silva R, et al. An- giotensin-(1-7) through receptor Mas mediates endothelial nitric oxide synthase activation via Akt-dependent pathways. Hyperten- sion, 2007,49 : 185-192.
  • 10Dai H, Gong Y, Xiao Z, et al. Decreased levels of serum An- giotensin-(1-7) in patients with pulmonary arterial hypertension due to congenital heart disease. Int J Cardiol,2014,176: 1399- 1401.

引证文献8

二级引证文献60

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部